Haemonetics Corporation
€57.17
EUR
Last updated on --.
24h volume520.22K
24h highest58.0851 EUR
24h lowest55.9065 EUR
24h Price movement-0.55%
HAE recent prices
24 Hours
-0.55%-€0.31738
30 days
+11.50%+€5.919
60 days
+21.47%+€10.14
90 days
+5.37%+€2.926
Key data
Previous close57.4891 EUR
Market cap2.33B EUR
Volume520.22K
P/E ratio15.430000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)3.3200 EUR
Net income (FY)150.89M EUR
Revenue (FY)1.13B EUR
Last report dateFeb 5, 2026
About Haemonetics Corporation
HeadquartersBOSTON
Employees (FY)3.02K
Revenue per employee (FY)375.07K EUR
Net income per employee (FY)49.91K EUR
Listed onNew York Stock Exchange
HAE conversion tables
 |  |
|---|---|
| 0.5 HAE | 28.58 EUR |
| 1 HAE | 57.17 EUR |
| 5 HAE | 285.85 EUR |
| 10 HAE | 571.71 EUR |
| |
|---|---|
| 0.5 EUR | 0.0087456 HAE |
| 1 EUR | 0.017491 HAE |
| 5 EUR | 0.087456 HAE |
| 10 EUR | 0.17491 HAE |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
HAE is trading at €57.17, -0.55% over the last 24 hours. Track live moves on the price chart at the top of this page.
The HAE stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. HAE is currently trading at €57.17, -0.55% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on HAE price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. HAE's P/E ratio is currently 15.430000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from HAE; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against HAE's historical range and other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.
Haemonetics Corporation's market cap is currently 2.33B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume520.22K
24h highest58.0851 EUR
24h lowest55.9065 EUR
24h Price movement-0.55%
Start trade with HAE Perpetual
Sign up to trade